Literature DB >> 7520225

Expression of c-kit ligand in human keratinocytes.

E Morita1, D G Lee, M Sugiyama, S Yamamoto.   

Abstract

The c-kit ligand is expressed on tissue-anchored stromal cells. It plays an important role in the development of c-kit-bearing cells, such as haematopoietic cells, germ cells, mast cells and melanocytes. In the present study, we used the reverse transcriptase-mediated polymerase chain reaction (PCR) technique to investigate whether human keratinocytes are able to express c-kit ligand mRNA. Two sets of primers were designed to distinguish two types of c-kit ligand mRNA (full-length type and spliced type). One set was used to amplify an 882-bp DNA fragment from the full-length type, and a 798-bp DNA fragment from the spliced type. Another set was used to amplify a 375-bp DNA fragment from the full-length type only. A cDNA fragment corresponding to the full-length type mRNA was amplified from a cDNA preparation of cultured human keratinocytes as well as from epidermis obtained by the suction blister technique. This result indicates the spontaneous transcription of full-length type mRNA of the c-kit ligand in human keratinocytes.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7520225     DOI: 10.1007/bf00387600

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN: 0340-3696            Impact factor:   3.017


  25 in total

1.  Deletion of the c-kit protooncogene in the human developmental defect piebald trait.

Authors:  R A Fleischman; D L Saltman; V Stastny; S Zneimer
Journal:  Proc Natl Acad Sci U S A       Date:  1991-12-01       Impact factor: 11.205

2.  Primer-directed enzymatic amplification of DNA with a thermostable DNA polymerase.

Authors:  R K Saiki; D H Gelfand; S Stoffel; S J Scharf; R Higuchi; G T Horn; K B Mullis; H A Erlich
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

3.  Expression of c-kit gene products in known cellular targets of W mutations in normal and W mutant mice--evidence for an impaired c-kit kinase in mutant mice.

Authors:  K Nocka; S Majumder; B Chabot; P Ray; M Cervone; A Bernstein; P Besmer
Journal:  Genes Dev       Date:  1989-06       Impact factor: 11.361

4.  Embryonic expression of a haematopoietic growth factor encoded by the Sl locus and the ligand for c-kit.

Authors:  Y Matsui; K M Zsebo; B L Hogan
Journal:  Nature       Date:  1990-10-18       Impact factor: 49.962

5.  Mutation of the KIT (mast/stem cell growth factor receptor) protooncogene in human piebaldism.

Authors:  L B Giebel; R A Spritz
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

6.  Interleukin-8 production from cultured human dermal fibroblasts by stimulation with supernatant of cultured human epidermal cells.

Authors:  E Morita; S Yamada; I Kimura; K Nakamura; Y Sugita; S Yamamoto
Journal:  Skin Pharmacol       Date:  1993

7.  In vitro cultivation of human tumors: establishment of cell lines derived from a series of solid tumors.

Authors:  D J Giard; S A Aaronson; G J Todaro; P Arnstein; J H Kersey; H Dosik; W P Parks
Journal:  J Natl Cancer Inst       Date:  1973-11       Impact factor: 13.506

Review 8.  Growth factors and tyrosine protein kinases in normal and malignant melanocytes.

Authors:  R Halaban
Journal:  Cancer Metastasis Rev       Date:  1991-06       Impact factor: 9.264

9.  DNA sequencing with chain-terminating inhibitors.

Authors:  F Sanger; S Nicklen; A R Coulson
Journal:  Proc Natl Acad Sci U S A       Date:  1977-12       Impact factor: 11.205

10.  In utero manipulation of coat color formation by a monoclonal anti-c-kit antibody: two distinct waves of c-kit-dependency during melanocyte development.

Authors:  S Nishikawa; M Kusakabe; K Yoshinaga; M Ogawa; S Hayashi; T Kunisada; T Era; T Sakakura; S Nishikawa
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

View more
  10 in total

1.  A Second Case of Sunitinib-associated Pyoderma Gangrenosum.

Authors:  Steven M Dean; Matthew Zirwas
Journal:  J Clin Aesthet Dermatol       Date:  2010-08

2.  Familial progressive hyper- and hypopigmentation: a report on a Chinese family and evidence for genetic heterogeneity.

Authors:  Fang Xiao-Kai; He Yue-Xi; Li Yan-Jia; Chen Li-Rong; Wang He-Peng; Sun Qing
Journal:  An Bras Dermatol       Date:  2017 May-Jun       Impact factor: 1.896

3.  TAK1 regulates SCF expression to modulate PKBα activity that protects keratinocytes from ROS-induced apoptosis.

Authors:  C R I Lam; M J Tan; S H Tan; M B Y Tang; P C F Cheung; N S Tan
Journal:  Cell Death Differ       Date:  2011-01-14       Impact factor: 15.828

4.  Biological characterization of human fibroblast-derived mitogenic factors for human melanocytes.

Authors:  G Imokawa; Y Yada; N Morisaki; M Kimura
Journal:  Biochem J       Date:  1998-03-15       Impact factor: 3.857

5.  Gain-of-function mutation of KIT ligand on melanin synthesis causes familial progressive hyperpigmentation.

Authors:  Zhi-Qiang Wang; Lizhen Si; Quan Tang; Debao Lin; Zhangjie Fu; Jing Zhang; Bin Cui; Yufei Zhu; Xianghua Kong; Min Deng; Yu Xia; Heng Xu; Weidong Le; Landian Hu; Xiangyin Kong
Journal:  Am J Hum Genet       Date:  2009-04-16       Impact factor: 11.025

6.  Hand-foot skin reaction increases with cumulative sorafenib dose and with combination anti-vascular endothelial growth factor therapy.

Authors:  Nilofer S Azad; Jeanny B Aragon-Ching; William L Dahut; Martin Gutierrez; William D Figg; Lokesh Jain; Seth M Steinberg; Maria L Turner; Elise C Kohn; Heidi H Kong
Journal:  Clin Cancer Res       Date:  2009-02-15       Impact factor: 12.531

7.  Sorafenib and sunitinib: A dermatologist's perspective.

Authors:  Vijendran Pragasam; Rajesh Verma; Biju Vasudevan
Journal:  Indian Dermatol Online J       Date:  2014-01

8.  A Clinical and Biochemical Evaluation of a Temperature-Controlled Continuous Non-Invasive Radiofrequency Device for the Treatment of Melasma.

Authors:  Soon-Hyo Kwon; Jung-Im Na; Chang-Hun Huh; Kyoung-Chan Park
Journal:  Ann Dermatol       Date:  2021-11-04       Impact factor: 1.444

9.  Role of keratinocytes in the development of vitiligo.

Authors:  Ai-Young Lee
Journal:  Ann Dermatol       Date:  2012-04-26       Impact factor: 1.444

10.  Concurrent hand-foot skin reaction and hair depigmentation with sunitinib: report of a case and literature review of kinase inhibitors and blocking antibodies.

Authors:  Shuchi Bansal; Kabir Sardana; Kishore Singh; Vijay K Garg
Journal:  Indian J Dermatol       Date:  2014-11       Impact factor: 1.494

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.